Mesoblast Shares Tumble as Losses Widen (ASX:MSB)
The MSB share price down 14%. The Mesoblast [ASX:MSB] posted a FY21 net loss of $98.8 million as the FDA asks for further trials of MSB’s emergency COVID treatment...
ASX:MSB
Mesoblast Share Price Bounce Back on Positive Trial Data (ASX:MSB)
It seems 2021 continues to be a tough year for the ever-volatile Mesoblast Ltd [ASX:MSB]. Thankfully though, today has brought some relief to shareholders. The MSB share price is up 7.38%...
Mesoblast Share Price Down — Secures a Dire Cash Injection (ASX:MSB)
Seven months ago Mesoblast Ltd [ASX:MSB] was on a tear. This high-flying biotech looked like it had the makings of something great.
Today though, that couldn't be further from the truth. The MSB share price is down 5.08%.
Mesoblast Share Price Crushed as Clinical Trial is Brought to a Halt
The Mesoblast Ltd [ASX:MSB] share price has been absolutely hammered today, trading 32.63% lower at time of writing. The result comes as the company shared some disheartening news. The trial of its remestemcel-L therapy...
Mesoblast Share Price Crashes on Heart Failure Therapy Results
Mesoblast Ltd [ASX:MSB] shares have taken a heavy hit today on the back of phase three chronic heart failure results for its rexlemestrocel-L therapy. The Mesoblast share price has tracked fairly well this year...
Mesoblast Share Price Up on FDA ‘Fast Track’ Designation (ASX:MSB)
At time of writing the Mesoblast Ltd [ASX:MSB] share price is up 7.26%. Soaring on the back of some exciting news. Their remestemcel-L treatment has secured ‘fast track’ status from the US Food & Drug Administration (FDA)...
Mesoblast Share Price Up on Novartis Collaboration (ASX:MSB)
At time of writing, the share price of Mesoblast Ltd [ASX:MSB] is up more than 14%, to trade at $3.73. We take a look at the details of Mesoblast’s latest announcement to work with pharma giant on remestemcel-L commercialisation
Mesoblast Share Price Up on Encouraging COVID-19 Trails (ASX:MSB)
At time of writing, the Mesoblast Ltd [ASX:MSB] share price is up 4.47%, trading at $3.27. The MSB share price moved higher after announcing positive outcomes in relation to Remestemcel-L phase three trials...
Mesoblast Enters Trading Halt — Good News on the Horizon? (ASX:MSB)
It’s no secret that Mesoblast Ltd [ASX:MSB] has been a breakout mid-cap in 2020. The stock has seen close to a fivefold (500%) increase in its share price since the March crash. Delivering some astonishing gains to shareholders who stuck with the company...
Mesoblast Share Price Up, Nears Major Milestone (ASX:MSB)
The share price of Mesoblast Ltd [ASX:MSB] is up on the back of news the company is due to complete their first interim analysis in early September. This is for their Phase 3 trial of their lead product for COVID-19 Acute Respiratory Distress Syndrome (ARDS)...